aplastic anemia

Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation.

Author(s):

Passweg JR, Marsh JC.

Primary Author:

Passweg JR

Journal Title:

Hematology Am Soc Hematol Educ Program

Original Publication Date:

Jan 2010

Newly diagnosed

Bone Marrow Disease(s):

aplastic anemia

Alternative donor transplantation for aplastic anemia.

Author(s):

Eapen M, Horowitz MM

Primary Author:

Eapen M

Journal Title:

Hematology Am Soc Hematol Educ Program

Original Publication Date:

Jan 2010

Patients with severe aplastic

Bone Marrow Disease(s):

aplastic anemia

Predicting response to immunosuppressive therapy in childhood aplastic anemia.

Author(s):

Yoshida N, Yagasaki H, Hama A, Takahashi Y, Kosaka Y, Kobayashi R, Yabe H, Kaneko T, Tsuchida M, Ohara A, Nakahata T, Kojima S.

Primary Author:

Yoshida N

Journal Title:

Haematologica

Original Publication Date:

May 2011

In

Bone Marrow Disease(s):

aplastic anemia

Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.

Author(s):

Valdez JM, Scheinberg P, Nunez O, Wu CO, Young NS, Walsh TJ.

Primary Author:

Valdez JM

Journal Title:

Clin Infect Dis

Original Publication Date:

Mar 2011

BACKGROUND:

Persistent

Bone Marrow Disease(s):

aplastic anemia

Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.

Author(s):

Kamio T, Ito E, Ohara A, Kosaka Y, Tsuchida M, Yagasaki H, Mugishima H, Yabe H, Morimoto A, Ohga S, Muramatsu H, Hama A, Kaneko T, Nagasawa M, Kikuta A, Osugi Y, Bessho F, Nakahata T, Tsukimoto I, Kojima S.

Primary Author:

Kamio T

Journal Title:

Haematologica

Original Publication Date:

Mar 2011

Background. Although the

Bone Marrow Disease(s):

aplastic anemia

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.

Author(s):

Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA.

Primary Author:

Pu JJ

Journal Title:

Eur J Haematol

Original Publication Date:

Mar 2011

Objective: Investigate the natural history of PNH

Bone Marrow Disease(s):

Clinical management of aplastic anemia.

Author(s):

Dezern AE, Brodsky RA.

Primary Author:

Dezern AE

Journal Title:

Expert Rev Hematol

Original Publication Date:

Apr 2011

Abstract

Acquired

Bone Marrow Disease(s):

aplastic anemia

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Author(s):

Marsh JC, Gupta V, Lim Z, Ho AY, Ireland R, Hayden J, Potter V, Koh MB, Islam M, Russell N, Marks DI, Mufti GJ, Pagliuca A.

Primary Author:

Marsh JC

Journal Title:

Blood

Original Publication Date:

Apr 2011

We evaluated a novel

Bone Marrow Disease(s):

aplastic anemia

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Author(s):

Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP

Primary Author:

Afable MG 2nd

Journal Title:

Blood

Original Publication Date:

Apr 2011

In

Bone Marrow Disease(s):

First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

Author(s):

Peinemann F, Grouven U, Kröger N, Bartel C, Pittler MH, Lange S

Primary Author:

Peinemann F

Journal Title:

PLoS One.

Original Publication Date:

Apr 2011

INTRODUCTION:

Acquired severe

Bone Marrow Disease(s):

aplastic anemia

Search form

aplastic anemia

BACKGROUND:

Abstract

INTRODUCTION: